Tuesday, September 27, 2016 |Latest E-book
You are here:
Sun Pharma
#

Sun Pharma

Articles

Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brands

Sep 06, 2016

Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brands

These 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharma's subsidiary in Japan beginning October 2016 #Sun Pharma #Novartis #drug firm #Mitsubishi Tanabe Pharma Corporation #14 brands
USFDA issues warning letter to ex-Sun Pharma US facility

Aug 26, 2016

USFDA issues warning letter to ex-Sun Pharma US facility

The Philadelphia plant is among the two facilities that Sun Pharma had sold to Frontida BioPharm in June this year, along with 15 products, for an undisclosed amount #Sun Pharma #USFDA #cGMP #warning letter #Frontida BioPharm
CEO salaries soar; average nears Rs 20 cr, AM Naik draws highest at Rs 66.14 cr in private sector

Aug 08, 2016

CEO salaries soar; average nears Rs 20 cr, AM Naik draws highest at Rs 66.14 cr in private sector

The analysis is based on the disclosures made by 20 out of the total 24 private sector companies on the Sensex, as the remaining four are yet to disclose their figures. #Infosys #Sun Pharma #ICICI Bank #SBI #HDFC #Cipla #Salary #Gautam Adani #Hero MotoCorp #Vishal Sikka
RPG Life Sciences enters deal to acquire Sun Pharma's 7 brands

Jul 27, 2016

RPG Life Sciences enters deal to acquire Sun Pharma's 7 brands

The move is in line with the company's strategy to focus on formulation business #Sun Pharma #BSE #RPG Lifesciences #ANDA #prescription brands #Biophore
Sun Pharma signs licensing deal with US arm for epilepsy drug

Jul 18, 2016

Sun Pharma signs licensing deal with US arm for epilepsy drug

The US subsidiary is also eligible for certain additional milestone payments and defined royalties linked to any future sales of Elepsia XRTM #Sun Pharma #BSE #USFDA #SPARC #Sun Pharma Advanced Research Company
Sun Pharma gets US subpoena over generic drugs pricing

May 29, 2016

Sun Pharma gets US subpoena over generic drugs pricing

The U.S. Department of Justice (DoJ) has subpoenaed India's largest drugmaker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday. The DoJ's antitrust division has also asked Sun Pharma's U.S #NewsTracker #Dr Reddy's #Sun Pharma #Subpoena #US Department of Justice #DoJ #doxycycline
Sun Pharma to sell 2 Ranbaxy units to Strides Arcolab for Rs 165 cr

Sep 19, 2015

Sun Pharma to sell 2 Ranbaxy units to Strides Arcolab for Rs 165 cr

The transaction is subject to approval from the Competition Commission of India and other customary closing conditions #NewsTracker #Sun Pharma #Ranbaxy #central nervous system #Strides Arocolab
Sun Pharma arm inks deal to buy US firm InSite Vision for $48 million

Sep 16, 2015

Sun Pharma arm inks deal to buy US firm InSite Vision for $48 million

Co to make a tender offer for all issued and outstanding common stocks of InSite Vision at $0.35 per share in cash #Sun Pharma #US FDA #InSite Vision #Ophthalmic business #specialty company #drug delivery platforms #New Drug Application